SEI Investments Co. (SEIC) Forms $72.78 Double Top; Profile of 5 Analysts Covering Curis, Inc. (CRIS)

SEI Investments Co. (NASDAQ:SEIC) Logo

Among 6 analysts covering Curis (NASDAQ:CRIS), 5 have Buy rating, 1 Sell and 0 Hold. Therefore 83% are positive. Curis had 8 analyst reports since August 10, 2015 according to SRatingsIntel. The stock has “Buy” rating by Guggenheim on Monday, October 23. The rating was maintained by Roth Capital on Monday, November 9 with “Buy”. The rating was initiated by FBR Capital on Tuesday, August 11 with “Outperform”. TH Capital maintained it with “Buy” rating and $5 target in Monday, November 9 report. The company was downgraded on Tuesday, September 1 by Zacks. Zacks downgraded the shares of CRIS in report on Monday, September 21 to “Sell” rating. See Curis, Inc. (NASDAQ:CRIS) latest ratings:

06/12/2017 Broker: Cowen & Co Rating: Buy
23/10/2017 Broker: Guggenheim Rating: Buy New Target: $7.0 Initiate

SEI Investments Co. (SEIC) formed double top with $77.15 target or 6.00% above today’s $72.78 share price. SEI Investments Co. (SEIC) has $11.45B valuation. The stock decreased 2.48% or $1.85 during the last trading session, reaching $72.78. About 519,651 shares traded. SEI Investments Co. (NASDAQ:SEIC) has risen 46.49% since April 7, 2017 and is uptrending. It has outperformed by 34.94% the S&P500.

Investors sentiment increased to 1.25 in Q4 2017. Its up 0.01, from 1.24 in 2017Q3. It increased, as 11 investors sold SEI Investments Co. shares while 115 reduced holdings. 62 funds opened positions while 95 raised stakes. 107.84 million shares or 1.88% less from 109.90 million shares in 2017Q3 were reported. Axa invested in 0.22% or 762,100 shares. Ashfield Capital Ltd Company has 11,008 shares for 0.1% of their portfolio. 89 were reported by Tci Wealth Advsrs. Asset Mgmt One Limited has invested 0.04% of its portfolio in SEI Investments Co. (NASDAQ:SEIC). Natl Asset invested in 4,376 shares. Moreover, Fayez Sarofim has 0% invested in SEI Investments Co. (NASDAQ:SEIC) for 7,900 shares. Fjarde Ap accumulated 47,389 shares or 0.05% of the stock. Moreover, Northern Tru Corporation has 0.02% invested in SEI Investments Co. (NASDAQ:SEIC). State Of Wisconsin Inv Board has invested 0.02% of its portfolio in SEI Investments Co. (NASDAQ:SEIC). Pub Sector Pension Invest Board reported 21,000 shares or 0.01% of all its holdings. Advisors Asset Management reported 3,536 shares. Acadian Asset Ltd Limited Liability Company reported 0.09% of its portfolio in SEI Investments Co. (NASDAQ:SEIC). Cwm Ltd Company holds 465 shares. Eagleclaw Managment Limited Company has 0.23% invested in SEI Investments Co. (NASDAQ:SEIC). 43,672 are owned by Metropolitan Life Insur Company Ny.

Analysts await SEI Investments Co. (NASDAQ:SEIC) to report earnings on April, 18. They expect $0.78 EPS, up 41.82% or $0.23 from last year’s $0.55 per share. SEIC’s profit will be $122.68M for 23.33 P/E if the $0.78 EPS becomes a reality. After $0.58 actual EPS reported by SEI Investments Co. for the previous quarter, Wall Street now forecasts 34.48% EPS growth.

Among 7 analysts covering SEI Investments (NASDAQ:SEIC), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. SEI Investments had 23 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Thursday, January 28 by Oppenheimer. The rating was maintained by Mizuho with “Buy” on Friday, October 20. The firm earned “Hold” rating on Tuesday, September 1 by Zacks. The rating was maintained by Sandler O’Neill on Thursday, February 1 with “Buy”. Oppenheimer maintained SEI Investments Co. (NASDAQ:SEIC) rating on Wednesday, July 26. Oppenheimer has “Buy” rating and $6000 target. As per Thursday, August 27, the company rating was upgraded by Credit Agricole. The firm earned “Hold” rating on Friday, September 1 by Keefe Bruyette & Woods. Mizuho maintained it with “Buy” rating and $90.0 target in Thursday, January 4 report. The company was maintained on Thursday, December 21 by Keefe Bruyette & Woods. The company was maintained on Friday, November 10 by Keefe Bruyette & Woods.

Since February 9, 2018, it had 0 buys, and 18 sales for $20.84 million activity. Klauder N Jeffrey sold 20,000 shares worth $1.48 million. ROMEO CARMEN sold $728,492 worth of stock or 9,600 shares. Another trade for 20,424 shares valued at $1.58 million was sold by Meyer Stephen. On Monday, March 5 the insider CRUDUP ROBERT sold $1.90M. $2.30M worth of stock was sold by MCGONIGLE DENNIS on Friday, March 9. $1.23 million worth of SEI Investments Co. (NASDAQ:SEIC) was sold by HEILIG KATHY. KLAUDER PAUL also sold $735,200 worth of SEI Investments Co. (NASDAQ:SEIC) on Friday, February 16.

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company has market cap of $88.61 million. The firm develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3-kinase enzymes, which is in Phase II clinical trials for relapsed or refractory diffuse large B-cell lymphoma, as well as in Phase I clinical trials for patients with solid tumors; CA-170, an oral small molecule drug candidate that is in Phase I clinical trials in patients with advanced solid tumors and lymphomas; CA-4948, an oral small molecule drug candidate, which is in preclinical stage for the treatment of hematologic cancers; and CA-327, an oral small molecule drug candidate that is in preclinical stage for the treatment of cancers. It currently has negative earnings. It is also developing Erivedge, an orally-administered small molecule hedgehog pathway inhibitor for advanced basal cell carcinoma, idiopathic pulmonary fibrosis, and myelofibrosis.

SEI Investments Co. (NASDAQ:SEIC) Institutional Positions Chart